Nivolumab in Combination With Chemotherapy, or Nivolumab in Combination With Ipilimumab, in Advanced EGFR-Mutant or ALK-Rearranged NSCLC
Clinical trial NCT03256136 · COMPLETED
Trial details
- NCT number
- NCT03256136
- Sponsor
- Massachusetts General Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-22
- Primary completion
- 2019-08-19
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.